ResearcherNanchang UniversityNo recent work listed

Jingyang Zhou

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-3259-7783; OpenAlex author ID A5002683556. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 1

Papers, trials and grants by year

2020: 1 paper · 2021: 1 paper

Papers 2

Mir-320b Inhibits Pancreatic Cancer Cell Proliferation by Targeting FOXM1. Co-author DOI 10.2174/1389201021999200917144704 ↗
Silencing of microRNA-135b inhibits invasion, migration, and stemness of CD24+CD44+ pancreatic cancer stem cells through JADE-1-dependent AKT/mTOR pathway. Co-author DOI 10.1186/s12935-020-01210-1 ↗

Closest collaborators

The 1 strongest of 1 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Wuyuan Zhou · 2 shared papers, 2020–2021 · strength 0.27
- Paper Mir-320b Inhibits Pancreatic Cancer Cell Proliferation by Targeting FOXM1. DOI 10.2174/1389201021999200917144704 ↗
- Paper Silencing of microRNA-135b inhibits invasion, migration, and stemness of CD24+CD44+ pancreatic cancer stem cells throug… DOI 10.1186/s12935-020-01210-1 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.